Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial
来源：康尔诺生物技术文献2018-05-17
Ji N, Zhang Y, Liu Y, Xie J, Wang Y, Hao S, Gao Z. Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial. JCI Insight. 2018 May 17;3(10):e99145. doi: 10.1172/jci.insight.99145.
相关资讯
Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients ...
2025-12-08
Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases
2025-12-08
Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of ...
2022-05-18
T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine...
2020-04-12
胃癌肝转移诊断与综合治疗中国专家共识（2019版）
2019-05-01